Use access key #2 to skip to page content.
$76.12 1.02 (1.36%)
9/5/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

View All Commentary (GENZ)

Recs

0

Avatar bclan13 (99.66) Submitted: 10/29/07 11:01 PM : Outperform Start Price: $73.30 GENZ Score: 22.77

I see accelerated drug development in Genzyme's near future; I love companies with relatively well developed therapeutic and diagnostics expertise, and the desire to codevelop products.

Report this Post Replies: 0 | Reply

Featured Broker Partners